<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2211234526
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2023
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        Azebat
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        AZELAIC ACID
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        % (W/W)
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Topical
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Cream
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Tube
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        24.50
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="BATTERJEE PHARMACETICAL FACTORY" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            BATTERJEE PHARMACETICAL FACTORY
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 651]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            BATTERJEE PHARMACEUTICAL FACTORY
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            BATTERJEE PHARMACETICAL FACTORY
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        D10AX03
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Azebat is a skin cream used to treat common acne (acne vulgaris).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Azebat Cream should only be used to treat acne. You should not use this medicine for any other skin condition.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Azebat attacks the bacterium called Propionibacterium acnes, which plays an essential part in causing acne. Azebat also reduces the growth of the harder outermost skin cells that block the pores of the skin to cause blackheads and whiteheads.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not use Azebat Cream</strong></p><p>&bull; If you are allergic to azelaic acid or any of the other ingredients of this medicine (listed in section 6).</p><p><strong>&nbsp;</strong></p><p><strong>Warnings and precautions</strong></p><p><strong>Talk to your doctor or pharmacist before using Azebat Cream</strong></p><p>Azebat is for external use on the skin only. You should not allow Azebat to come into contact with your eyes, mouth or other mucous membranes. If it does, wash the eyes, mouth or other mucous membranes immediately with large amounts of cool water.</p><p>Rarely, it has been reported that in some patients with asthma who were treated with azelaic acid worsening of asthma symptoms had occurred.</p><p>Azebat is not recommended for use in children below the age of 12 due to a lack of data on safety and efficacy.</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>Other medicines and Azebat </strong></p><p>Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines.</p><p>&nbsp;</p><p><strong>Pregnancy and breast-feeding </strong></p><p>There is limited experience with the use of the active substance azelaic acid during pregnancy. If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.</p><p>Infants must not come into contact with treated skin or breast.</p><p>&nbsp;</p><p><strong>Driving and using machines </strong></p><p>Azebat has no influence on the ability to drive and use machines.</p><p><strong>&nbsp;</strong></p><p><strong>This medicine contains 2 mg of benzoic acid in each g. </strong></p><p>Benzoic acid may cause local irritation.</p><p><strong>This medicine contains 125 mg propylene glycol in each g.</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Always use this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure. </strong></p><p><strong>&nbsp;</strong></p><p><strong>Adults and Adolescents (12 &ndash; 18 years of age) </strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; First, thoroughly wash with plain water the whole area to be treated. If the skin is greasy use a mild skin cleanser. Dry the skin thoroughly before applying Azebat.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Unless your doctor has told you otherwise, <strong>start treatment with Azebat twice a day. </strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>If your skin is very sensitive </strong>use Azebat once a day, in the evening during the first week of treatment. Then change to twice a day.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>The amount of Azebat you should use will depend on the size of the area to be treated: </strong></p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; As a guide, if the whole of your face is affected, use 2.5 cm (approx. 0.5 g) &nbsp;of cream each time you apply Azebat.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have acne on your chest and back, as well as your face, adjust the amount of cream accordingly.</p><p>&nbsp;</p><p>Use the cream regularly. Rub it in gently.</p><p><strong>Wash your hands thoroughly after using Azebat. </strong></p><p>How long Azebat has to be used varies from person to person. It depends upon how</p><p>bad your acne is when you start treatment. You should see a distinct improvement after about 4 weeks. To get the best effect you will probably have to use Azebat regularly for several months. <strong>However, you should not use Azebat for more than 12 months at any time. </strong></p><p><strong>&nbsp;</strong></p><p><strong>If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p><strong>Reasons to stop using Azebat </strong></p><p>Stop using Azebat and see your doctor as soon as possible if you think you are having an allergic reaction (e.g. rash) to Azebat.</p><p>Occasionally local skin irritation occurs with Azebat, usually at the start of treatment. In most cases, the irritation is mild and usually gets better as treatment continues. <strong>If skin irritation remains troublesome: </strong></p><p>&bull;&nbsp;&nbsp; reduce the amount of Azebat you apply each time</p><p>&bull;&nbsp;&nbsp; or apply it only once a day</p><p>&bull;&nbsp;&nbsp; or stop treatment temporarily.</p><p><strong>If skin irritation still remains troublesome tell your doctor. </strong></p><p>The following side effects are based on reports from clinical studies and post-marketing surveillance with Azebat Cream starting with the most frequent ones:</p><p><strong>Very common </strong>(may affect more than 1 in 10 people): burning, itching or abnormal redness of the skin (erythema) at the site of application.</p><p><strong>Common </strong>(may affect up to 1 in 10 people): scaling, pain, dryness, skin discolouration or irritation at the site of application.</p><p><strong>Uncommon </strong>(may affect up to 1 in 100 people): greasy skin, acne or loss of skin colour, tingling, dermatitis, discomfort or swelling at the site of application.</p><p><strong>Rare </strong>(may affect up to 1 in 1,000 people): cracking of the lips, vesicles (small blisters), eczema, ulceration, warmth at the site of application, allergic reaction, rash at the site of application.</p><p><strong>Not Known </strong>(cannot be estimated from the available data)<sup>*</sup>: skin swelling, eye swelling, swelling face (which may occur with hypersensitivity), rash, urticaria, worsening of asthama.</p><p><sup>&nbsp;</sup></p><p><sup>*</sup> These additional side effects have been reported in patients using Azebat Cream</p><p>(frequency unknown) since marketing approval.</p><p><strong>&nbsp;</strong></p><p><strong>Reporting of side effects</strong></p><p>If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.</p><p>&nbsp;</p><p><strong>To report any side effect(s):</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>S</strong><strong>audi Arabia:</strong></p><p><!--[if gte vml 1]><v:group
 id="Group_x0020_31" o:spid="_x0000_s1037" style='position:absolute;
 margin-left:74.25pt;margin-top:7.95pt;width:432.2pt;height:73.5pt;z-index:-251653120;
 mso-position-horizontal-relative:page' coordorigin="1789,-887" coordsize="8644,1984"
 o:gfxdata="UEsDBBQABgAIAAAAIQC75UiUBQEAAB4CAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbKSRvU7DMBSF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" o:allowincell="f">
 <v:shape id="Freeform_x0020_22" o:spid="_x0000_s1038" style='position:absolute;
  left:1810;top:-867;width:8603;height:0;visibility:visible;mso-wrap-style:square;
  v-text-anchor:top' coordsize="8603,0" o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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" path="m,l8603,e" filled="f" strokeweight=".37392mm">
  <v:path arrowok="t" o:connecttype="custom" o:connectlocs="0,0;8603,0"
   o:connectangles="0,0"/>
 </v:shape><v:shape id="Freeform_x0020_23" o:spid="_x0000_s1039" style='position:absolute;
  left:1800;top:-877;width:0;height:1963;visibility:visible;mso-wrap-style:square;
  v-text-anchor:top' coordsize="0,1963" o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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" path="m,l,1963e" filled="f" strokeweight=".37392mm">
  <v:path arrowok="t" o:connecttype="custom" o:connectlocs="0,0;0,1963"
   o:connectangles="0,0"/>
 </v:shape><v:shape id="Freeform_x0020_24" o:spid="_x0000_s1040" style='position:absolute;
  left:1810;top:1077;width:8603;height:0;visibility:visible;mso-wrap-style:square;
  v-text-anchor:top' coordsize="8603,0" o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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==
" path="m,l8603,e" filled="f" strokeweight=".37392mm">
  <v:path arrowok="t" o:connecttype="custom" o:connectlocs="0,0;8603,0"
   o:connectangles="0,0"/>
 </v:shape><v:shape id="Freeform_x0020_25" o:spid="_x0000_s1041" style='position:absolute;
  left:10422;top:-877;width:0;height:1963;visibility:visible;mso-wrap-style:square;
  v-text-anchor:top' coordsize="0,1963" o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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==
" path="m,l,1963e" filled="f" strokeweight="1.06pt">
  <v:path arrowok="t" o:connecttype="custom" o:connectlocs="0,0;0,1963"
   o:connectangles="0,0"/>
 </v:shape><w:wrap anchorx="page"/>
</v:group><![endif]--></p><p>&nbsp;The National Pharmacovigilance Centre (NPC):</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SFDA Call Center: 19999</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: &nbsp;<u>https://ade.sfda.gov.sa/</u></p><p>&nbsp;</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>United Arab Emirates</strong></p><p><!--[if gte vml 1]><v:shapetype id="_x0000_t202" coordsize="21600,21600"
 o:spt="202" path="m,l,21600r21600,l21600,xe">
 <v:stroke joinstyle="miter"/>
 <v:path gradientshapeok="t" o:connecttype="rect"/>
</v:shapetype><v:shape id="Text_x0020_Box_x0020_30" o:spid="_x0000_s1036"
 type="#_x0000_t202" style='position:absolute;margin-left:0;margin-top:10.1pt;
 width:435.5pt;height:72.8pt;z-index:251666432;visibility:visible;
 mso-wrap-style:square;mso-width-percent:0;mso-height-percent:0;
 mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;mso-wrap-distance-right:9pt;
 mso-wrap-distance-bottom:0;mso-position-horizontal:left;
 mso-position-horizontal-relative:margin;mso-position-vertical:absolute;
 mso-position-vertical-relative:text;mso-width-percent:0;mso-height-percent:0;
 mso-width-relative:page;mso-height-relative:page;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQC75UiUBQEAAB4CAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbKSRvU7DMBSF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">
 <v:textbox inset="0,0,0,0"/>
 <w:wrap anchorx="margin"/>
</v:shape><![endif]--></p><table cellpadding="0" cellspacing="0" align="left"><tbody><tr><td>&nbsp;</td></tr><tr><td>&nbsp;</td><td><table cellpadding="0" cellspacing="0" style="width:100%"><tbody><tr><td><p>Pharmacovigilance &amp; Medical Device section</p><p>P.O.Box: 1853</p><p>Tel: 80011111</p><p>Email : pv@mohap.gov.ae</p><p>Drug Department Ministry of Health &amp; Prevention, Dubai, UAE</p></td></tr></tbody></table></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Other GCC States:</strong></p><p><!--[if gte vml 1]><v:group
 id="Group_x0020_25" o:spid="_x0000_s1031" style='position:absolute;
 margin-left:70.6pt;margin-top:5.5pt;width:436.05pt;height:24.55pt;z-index:-251652096;
 mso-position-horizontal-relative:page' coordorigin="1789,-26" coordsize="8644,491"
 o:gfxdata="UEsDBBQABgAIAAAAIQC75UiUBQEAAB4CAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbKSRvU7DMBSF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" o:allowincell="f">
 <v:shape id="Freeform_x0020_27" o:spid="_x0000_s1032" style='position:absolute;
  left:1810;top:-5;width:8603;height:0;visibility:visible;mso-wrap-style:square;
  v-text-anchor:top' coordsize="8603,0" o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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==
" path="m,l8603,e" filled="f" strokeweight=".37392mm">
  <v:path arrowok="t" o:connecttype="custom" o:connectlocs="0,0;8603,0"
   o:connectangles="0,0"/>
 </v:shape><v:shape id="Freeform_x0020_28" o:spid="_x0000_s1033" style='position:absolute;
  left:1800;top:-15;width:0;height:469;visibility:visible;mso-wrap-style:square;
  v-text-anchor:top' coordsize="0,469" o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH
70i8Q+QralM4IITa7kDhCAiNB7ASt43WOlEcyvb2pNu4IODoPz9/n1xv9vOkForiPDdwXVagiI23
jocG3rdPxR0oScgWJ8/UwIEENu3lRb09BBKV0ywNjCmFe63FjDSjlD4Q50nv44wpl3HQAc0OB9I3
VXWrjedEnIq03oC27qjHjympx31un0wiTQLq4bS4shrAECZnMGVTvbD9QSnOhDInjzsyuiBXWQP0
r4R18jfgnHvJr4nOknrFmJ5xzhraRtHWf3Kkpfz/yGo5S+H73hkquyhdjr3R8m2lj09svwAAAP//
AwBQSwMEFAAGAAgAAAAhAFr0LFu/AAAAFQEAAAsAAABfcmVscy8ucmVsc2zPwWrDMAwG4Ptg72B0
X5TuUMaI01uh19I+gLGVxCy2jGSy9e1nemrHjpL4P0nD4SetZiPRyNnCruvBUPYcYp4tXC/Htw8w
Wl0ObuVMFm6kcBhfX4Yzra62kC6xqGlKVgtLreUTUf1CyWnHhXKbTCzJ1VbKjMX5LzcTvvf9HuXR
gPHJNKdgQU5hB+ZyK23zHztFL6w81c5zQp6m6P9TMfB3PtPWFCczVQtB9N4U2rp2HOA44NMz4y8A
AAD//wMAUEsDBBQABgAIAAAAIQArgj3UxQAAANsAAAAPAAAAZHJzL2Rvd25yZXYueG1sRI9Pa8JA
FMTvBb/D8gQvRTd6sBpdpbEIghT8i3h7ZJ9JMPs2ZNcYv323UOhxmJnfMPNla0rRUO0KywqGgwgE
cWp1wZmC03Hdn4BwHlljaZkUvMjBctF5m2Os7ZP31Bx8JgKEXYwKcu+rWEqX5mTQDWxFHLybrQ36
IOtM6hqfAW5KOYqisTRYcFjIsaJVTun98DAKOHnf+ibZfF1vq+HuPE2+ZXuZKtXrtp8zEJ5a/x/+
a2+0gtEH/H4JP0AufgAAAP//AwBQSwECLQAUAAYACAAAACEA2+H2y+4AAACFAQAAEwAAAAAAAAAA
AAAAAAAAAAAAW0NvbnRlbnRfVHlwZXNdLnhtbFBLAQItABQABgAIAAAAIQBa9CxbvwAAABUBAAAL
AAAAAAAAAAAAAAAAAB8BAABfcmVscy8ucmVsc1BLAQItABQABgAIAAAAIQArgj3UxQAAANsAAAAP
AAAAAAAAAAAAAAAAAAcCAABkcnMvZG93bnJldi54bWxQSwUGAAAAAAMAAwC3AAAA+QIAAAAA
" path="m,l,470e" filled="f" strokeweight=".37392mm">
  <v:path arrowok="t" o:connecttype="custom" o:connectlocs="0,0;0,470"
   o:connectangles="0,0"/>
 </v:shape><v:shape id="Freeform_x0020_29" o:spid="_x0000_s1034" style='position:absolute;
  left:1810;top:445;width:8603;height:0;visibility:visible;mso-wrap-style:square;
  v-text-anchor:top' coordsize="8603,0" o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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" path="m,l8603,e" filled="f" strokeweight=".37392mm">
  <v:path arrowok="t" o:connecttype="custom" o:connectlocs="0,0;8603,0"
   o:connectangles="0,0"/>
 </v:shape><v:shape id="Freeform_x0020_30" o:spid="_x0000_s1035" style='position:absolute;
  left:10422;top:-15;width:0;height:469;visibility:visible;mso-wrap-style:square;
  v-text-anchor:top' coordsize="0,469" o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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" path="m,l,470e" filled="f" strokeweight="1.06pt">
  <v:path arrowok="t" o:connecttype="custom" o:connectlocs="0,0;0,470"
   o:connectangles="0,0"/>
 </v:shape><w:wrap anchorx="page"/>
</v:group><![endif]--></p><p>&nbsp;&nbsp;&nbsp; Please contact the relevant competent authority.</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>&nbsp;</strong></p><p><strong>Council of Arab Health Ministers</strong></p><p>&nbsp;</p><p>&nbsp;</p><p><strong>This is a Medicament</strong></p><p><!--[if gte vml 1]><v:group
 id="Group_x0020_20" o:spid="_x0000_s1026" style='position:absolute;
 margin-left:68.6pt;margin-top:124.3pt;width:505.5pt;height:127.7pt;z-index:-251651072;
 mso-position-horizontal-relative:page;mso-position-vertical-relative:page'
 coordorigin="1785,3260" coordsize="8643,4460" o:gfxdata="UEsDBBQABgAIAAAAIQC75UiUBQEAAB4CAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbKSRvU7DMBSF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" o:allowincell="f">
 <v:shape id="Freeform_x0020_32" o:spid="_x0000_s1027" style='position:absolute;
  left:1814;top:3290;width:8584;height:0;visibility:visible;mso-wrap-style:square;
  v-text-anchor:top' coordsize="8584,0" o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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==
" path="m,l8583,e" filled="f" strokeweight="1.54pt">
  <v:path arrowok="t" o:connecttype="custom" o:connectlocs="0,0;8583,0"
   o:connectangles="0,0"/>
 </v:shape><v:shape id="Freeform_x0020_33" o:spid="_x0000_s1028" style='position:absolute;
  left:1800;top:3276;width:0;height:4429;visibility:visible;mso-wrap-style:square;
  v-text-anchor:top' coordsize="0,4429" o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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" path="m,l,4429e" filled="f" strokeweight=".54325mm">
  <v:path arrowok="t" o:connecttype="custom" o:connectlocs="0,0;0,4429"
   o:connectangles="0,0"/>
 </v:shape><v:shape id="Freeform_x0020_34" o:spid="_x0000_s1029" style='position:absolute;
  left:1814;top:7690;width:8584;height:0;visibility:visible;mso-wrap-style:square;
  v-text-anchor:top' coordsize="8584,0" o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH
70i8Q+QralM4IITa7kDhCAiNB7ASt43WOlEcyvb2pNu4IODoPz9/n1xv9vOkForiPDdwXVagiI23
jocG3rdPxR0oScgWJ8/UwIEENu3lRb09BBKV0ywNjCmFe63FjDSjlD4Q50nv44wpl3HQAc0OB9I3
VXWrjedEnIq03oC27qjHjympx31un0wiTQLq4bS4shrAECZnMGVTvbD9QSnOhDInjzsyuiBXWQP0
r4R18jfgnHvJr4nOknrFmJ5xzhraRtHWf3Kkpfz/yGo5S+H73hkquyhdjr3R8m2lj09svwAAAP//
AwBQSwMEFAAGAAgAAAAhAFr0LFu/AAAAFQEAAAsAAABfcmVscy8ucmVsc2zPwWrDMAwG4Ptg72B0
X5TuUMaI01uh19I+gLGVxCy2jGSy9e1nemrHjpL4P0nD4SetZiPRyNnCruvBUPYcYp4tXC/Htw8w
Wl0ObuVMFm6kcBhfX4Yzra62kC6xqGlKVgtLreUTUf1CyWnHhXKbTCzJ1VbKjMX5LzcTvvf9HuXR
gPHJNKdgQU5hB+ZyK23zHztFL6w81c5zQp6m6P9TMfB3PtPWFCczVQtB9N4U2rp2HOA44NMz4y8A
AAD//wMAUEsDBBQABgAIAAAAIQDDVqagwwAAANsAAAAPAAAAZHJzL2Rvd25yZXYueG1sRI9Pi8Iw
FMTvgt8hPMGbpioUrUZZBP8d9qC7i9dn87YtJi+libV++83Cwh6HmfkNs9p01oiWGl85VjAZJyCI
c6crLhR8fuxGcxA+IGs0jknBizxs1v3eCjPtnnym9hIKESHsM1RQhlBnUvq8JIt+7Gri6H27xmKI
simkbvAZ4dbIaZKk0mLFcaHEmrYl5ffLwypID+Z9YRZUf7XH+z49Ed+u7qrUcNC9LUEE6sJ/+K99
1AqmM/j9En+AXP8AAAD//wMAUEsBAi0AFAAGAAgAAAAhANvh9svuAAAAhQEAABMAAAAAAAAAAAAA
AAAAAAAAAFtDb250ZW50X1R5cGVzXS54bWxQSwECLQAUAAYACAAAACEAWvQsW78AAAAVAQAACwAA
AAAAAAAAAAAAAAAfAQAAX3JlbHMvLnJlbHNQSwECLQAUAAYACAAAACEAw1amoMMAAADbAAAADwAA
AAAAAAAAAAAAAAAHAgAAZHJzL2Rvd25yZXYueG1sUEsFBgAAAAADAAMAtwAAAPcCAAAAAA==
" path="m,l8583,e" filled="f" strokeweight=".54325mm">
  <v:path arrowok="t" o:connecttype="custom" o:connectlocs="0,0;8583,0"
   o:connectangles="0,0"/>
 </v:shape><v:shape id="Freeform_x0020_35" o:spid="_x0000_s1030" style='position:absolute;
  left:10413;top:3276;width:0;height:4429;visibility:visible;mso-wrap-style:square;
  v-text-anchor:top' coordsize="0,4429" o:gfxdata="UEsDBBQABgAIAAAAIQDb4fbL7gAAAIUBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbHyQz07DMAyH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" path="m,l,4429e" filled="f" strokeweight="1.54pt">
  <v:path arrowok="t" o:connecttype="custom" o:connectlocs="0,0;0,4429"
   o:connectangles="0,0"/>
 </v:shape><w:wrap anchorx="page" anchory="page"/>
</v:group><![endif]--></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicament is a product which affects your health and its consumption contrary to instructions is dangerous for you.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Follow strictly the doctor&rsquo;s prescription, the method of use and the instructions of the pharmacist who sold the medicament.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The doctor and the pharmacist are the experts in medicines, their benefits and risks.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not by yourself interrupt the period of treatment prescribed for you.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not repeat the same prescription without consulting your doctor.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Keep all medicaments out of reach of children.</p><p>&nbsp;</p><p>&nbsp;</p><p>Council of Arab Health Ministers</p><p>Union of Arab Pharmacists</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Keep this medicine out of the sight and reach of children.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not use this medicine after the expiry date which is stated on the tube and carton after the word &#39;EXP&#39;.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not store above 30&deg;C.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; To be used within 6 months from the first opening of the tube</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>What Azebat contains</strong></p><p>Each gm contains</p><p><strong>Active ingredient is </strong>azelaic acid. Each one gram of Azebat cream contains<strong> </strong>200 mg (20% w/w) of azelaic acid.</p><p><strong>Inactive ingredients:</strong></p><p>Glyceryl Stearate/ Cetearyl Alcohol /Cetyl Palmitate /Cocoglycerides (CUTINA CBS), PEG &ndash; 5 Glyceryl stearate (Arlacel 983), Glycerine, Propylene Glycol, Cetearyl Octanoate (PCL Liquid 100), Benzoic acid, purified water.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Azebat is White to yellowish-white smooth homogeneous cream. It is available in an aluminium tube of  30 g inside a carton box along with a patient information leaflet.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Batterjee pharmaceutical Factory (BATTERJEE PHARMA)</p><p>Plot E2, Phase 4, Industrial City, Jeddah, Saudi Arabia</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised in March 2023
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أزيبات هو كريم جلدي يستخدم لعلاج حب الشباب الشائع.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يجب استخدام كريم أزيبات فقط لعلاج حب الشباب. يجب عدم استخدام هذا الدواء لأي حالة جلدية أخرى.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يهاجم أزيبات البكتيريا المسماة البكتيريا البروبيونية العدية، والتي تلعب دورًا أساسيًا في ظهور حب الشباب. يقلل أزيبات أيضًا من نمو خلايا الجلد الخارجية الأكثر صلابة التي تسد مسام الجلد لتسبب الرؤوس السوداء والرؤوس البيضاء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">لا تستخدم&nbsp;كريم أزيبات</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كان لديك حساسية من حمض الأزيلايك أو أي من المكونات الأخرى لهذا الدواء (المدرجة في القسم 6).</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>التحذيرات والاحتياطات</strong></p><p>تحدث إلى طبيبك أو الصيدلي قبل استخدام كريم أزيبات</p><p>يقتصر استخدام كريم أزيبات على الاستخدام الخارجي على الجلد فقط. ولا ينبغي أن يلامس العينين أو الفم أو أي أغشية مخاطية أخرى. وفي حال حدوث ذلك، قم بغسل عينيك أو فمك أو أي أغشية مخاطية أخرى على الفور بكمية كبيرة من الماء البارد.</p><p>نادرًا ما تم الإبلاغ عن حدوث تفاقم في أعراض الربو لدى بعض مرضى الربو الذين عولجوا بحمض الأزيلايك.</p><p>لا ينصح باستخدام كريم أزيبات للأطفال الذين تقل أعمارهم عن 12 عامًا بسبب نقص البيانات المتعلقة بالسلامة والفعالية.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p><strong>الأدوية الأخرى وكريم</strong><strong> أزيبات</strong></p><p>أخبر طبيبك أو الصيدلي إذا كنت تستخدم أو استخدمت مؤخرًا أو قد تستخدم أي أدوية أخرى.</p><p>&nbsp;</p><p><strong>الحمل والرضاعة الطبيعية</strong></p><p>لا توجد معلومات كافية حول استخدام المادة الفعالة ( حمض الأزيلايك ) خلال فترة الحمل. لذلك في حالات الحمل أو الرضاعة، أو حتى التخطيط للإنجاب، اسألي طبيبك أو الصيدلي قبل استخدام كريم أزيبات.</p><p dir="RTL">لا يجب أن يلامس الرضع الجلد أو الثدي المعالج بكريم أزيبات.</p><p>&nbsp;</p><p>&nbsp;</p><p dir="RTL"><strong>تأثير </strong><strong>كريم أزيبات</strong> <strong>على القيادة واستخدام الآلات</strong></p><p>ليس لـكريم أزيبات أي تأثير على القدرة على القيادة واستخدام الآلات.</p><p>&nbsp;</p><p><strong>يحتوي هذا الدواء على 2 مجم من حمض البنزويك في كل جرام.</strong></p><p>قد يسبب حمض البنزويك تهيج موضعي.</p><p>&nbsp;</p><p><strong>يحتوي هذا الدواء على 125 مجم بروبيلين جليكول في كل جرام</strong>.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>استخدم هذا الدواء دائمًا تمامًا كما أخبرك طبيبك أو الصيدلي. استشر طبيبك أو الصيدلي إذا لم تكن متأكدًا.</p><p><u>الكبار والمراهقون (12 - 18 سنة)</u></p><p dir="RTL">&middot;&nbsp;&nbsp; أولاً، اغسل المنطقة المراد معالجتها بالكامل بالماء. إذا كانت البشرة دهنية، استخدم منظفًا أو غسولًا لطيفًا، مع التأكد من تجفيف الجلد جيدًا قبل وضع الكريم.</p><p dir="RTL">&middot;&nbsp;&nbsp; ما لم يخبرك الطبيب بخلاف ذلك، ابدأ باستخدام الكريم مرتين يوميًا.</p><p dir="RTL">&middot;&nbsp;&nbsp; إذا كانت بشرتك حساسة للغاية، استخدم الكريم مرة واحدة في المساء خلال الأسبوع الأول من العلاج، ثم قم بزيادة الجرعة لتصبح مرتين يوميًا</p><p dir="RTL">&middot;&nbsp;&nbsp; كمية الكريم التي يجب عليك استخدامها تعتمد على حجم المنطقة المراد علاجها. فإذا كان الوجه كله متأثرًا بحب الشباب، استخدم 2.5 سم (0.5 جم تقريبًا) من الكريم في كل مرة.</p><p dir="RTL">&middot;&nbsp;&nbsp; إذا كنت تعاني من حب الشباب على الصدر والظهر إلى جانب الوجه، قم بتحديد الكمية وفقًا للمثال السابق.</p><p dir="RTL">&middot;&nbsp;&nbsp; استخدم الكريم بشكل منتظم، ودلك المنطقة المصابة برفق.</p><p dir="RTL">&middot;&nbsp;&nbsp; اغسل يديك جيدًا بعد استخدام كريم أزيبات.</p><p dir="RTL">&middot;&nbsp;&nbsp; تختلف مدة استخدام الكريم من شخص لآخر، كما يعتمد الأمر على شدة وحدة مشكلة حب الشباب عند بدء العلاج. وعادة ما يُلاحظ التحسن في غضون 4 أسابيع من الاستخدام، لكن الحصول على أفضل النتائج يتطلب استعمال الكريم بانتظام لعدة أشهر ومع ذلك، يجب ألا تستخدم كريم أزيبات لأكثر من 12 شهرًا في أي وقت.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا كان لديك أي أسئلة أخرى عن استخدام الدواء، اسأل الطبيب أو الصيدلي.</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">كما هو الحال مع جميع الأدوية، يمكن أن يسبّب هذا الدواء بعض الآثار الجانبية، مع العلم أنها لا تصيب الجميع.</p><p><strong>أسباب التوقف عن استخدام كريم </strong><strong>أزيبات</strong></p><p dir="RTL">توقف فورًا عن استخدام أزيبات واستشر طبيبك في أقرب وقت ممكن إذا كنت تعتقد أنك تعاني من رد فعل تحسسي مثل الطفح الجلدي تجاه الكريم.</p><p dir="RTL">عادة مع بداية العلاج قد يحدث تهيج موضعي للجلد، ولكن في معظم الحالات يكون التهيج بسيطًا وغالبًا ما يتحسن بالعلاج. إذا استمر التهيج:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قلل كمية أزيبات التي تستخدمها في كل مرة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أو استخدم الكريم مرة واحدة فقط يوميًا.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أو توقف عن استخدامه بشكل مؤقت.</p><p><strong>إذا استمر تهيج الجلد بشكل مزعج، أخبر طبيبك.</strong></p><p>&nbsp;</p><p>تستند الآثار الجانبية التالية إلى تقارير الدراسات السريرية ومراقبة ما بعد التسويق لكريم أزيبات بدءًا من أكثر الآثار شيوعًا:</p><p dir="RTL"><strong>آثار جانبية</strong> <strong>شائعة جدا (</strong><strong>التي قد تصيب أكثر من 1 من كل 10 أشخاص)</strong></p><ul><li dir="RTL">حرقان.</li><li dir="RTL">حكة أو احمرار غير طبيعي.</li></ul><p dir="RTL">&nbsp;</p><p>آثار جانبية شائعة (التي قد تصيب 1 من كل 10 أشخاص)</p><ul><li dir="RTL">تقشر.</li><li dir="RTL">ألم.</li><li dir="RTL">جفاف.</li><li dir="RTL">تغير لون الجلد أو تهيجه.</li></ul><p>&nbsp;</p><p>آثار جانبية غير شائعة (التي قد تصيب 1 من كل 100 أشخاص)</p><ul><li dir="RTL">بشرة دهنية.</li><li dir="RTL">حب شباب.</li><li dir="RTL">فقدان لون الجلد.</li><li dir="RTL">وخز.</li><li dir="RTL">التهاب الجلد.</li><li dir="RTL">شعور بعدم الراحة أو التورم.</li></ul><p dir="RTL">&nbsp;</p><p>آثار جانبية نادرة التي قد تصيب 1 من كل 1000 أشخاص)</p><ul><li dir="RTL">تشقق الشفاه.</li><li dir="RTL">بثور صغيرة.</li><li dir="RTL">إكزيما.</li><li dir="RTL">تقرح.</li><li dir="RTL">دفء أو حرارة.</li><li dir="RTL">رد فعل تحسسي.</li><li dir="RTL">طفح جلدي.</li></ul><p dir="RTL">&nbsp;</p><p><strong>آثار جانبية غير معروف معدل تكرارها</strong><strong><sup>*</sup></strong><strong> </strong><strong>(لا يمكن تقدير معدل التكرار من البيانات المتاحة)</strong></p><ul><li dir="RTL">تورم الجلد.</li><li dir="RTL">تورم العينين.</li><li dir="RTL">تورم الوجه (يحدث عادة مع فرط الحساسية).</li><li dir="RTL">طفح جلدي.</li><li dir="RTL">شري.</li><li dir="RTL">تفاقم&nbsp;الربو.</li></ul><p><strong><sup>*</sup></strong> تم الإبلاغ عن هذه الآثار الجانبية الإضافية في المرضى الذين يستخدمون كريم أزيبات</p><p>(معدل التكرار غير معروف) منذ الموافقة على التسويق.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الإبلاغ عن الآثار الجانبيّة</strong></p><p dir="RTL">إن كان لديك آثار جانبية أو لاحظت آثار جانبية غير مذكورة في هذه النشرة، فضلًا ابلغ الطبيب أو الصيدلي.</p><p>&nbsp;</p><p dir="RTL"><strong>للإبلاغ حول الآثار الجانبية التي قد تحدث يرجي التواصل عبر العناوين التالية</strong><strong>:</strong></p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>المملكة العربية السعودية</strong><strong>:</strong></p><p dir="RTL"><!--[if gte vml 1]><v:shapetype id="_x0000_t202"
 coordsize="21600,21600" o:spt="202" path="m,l,21600r21600,l21600,xe">
 <v:stroke joinstyle="miter"/>
 <v:path gradientshapeok="t" o:connecttype="rect"/>
</v:shapetype><v:shape id="Text_x0020_Box_x0020_3" o:spid="_x0000_s1028"
 type="#_x0000_t202" style='position:absolute;left:0;text-align:left;
 margin-left:86.25pt;margin-top:4.35pt;width:387.1pt;height:65.25pt;z-index:251663360;
 visibility:visible;mso-wrap-style:square;mso-width-percent:0;
 mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:text;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:0;mso-width-relative:page;
 mso-height-relative:page;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQC75UiUBQEAAB4CAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbKSRvU7DMBSF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">
 <v:textbox>
  <![if !mso]>
  <table cellpadding=0 cellspacing=0 width="100%">
   <tr>
    <td><![endif]>
    <div>
    <p dir=RTL style='margin:0in;margin-bottom:.0001pt;text-align:right;
    direction:rtl;unicode-bidi:embed'><span dir=LTR style='color:black'>- </span><span
    lang=AR-SA style='color:black'>المركز الوطني للتيقظ الدوائي:</span><span
    dir=LTR style='color:black'><o:p></o:p></span></p>
    <p dir=RTL style='margin:0in;margin-bottom:.0001pt;text-align:right;
    direction:rtl;unicode-bidi:embed'><span dir=RTL></span><span dir=RTL></span><span
    lang=AR-SA style='color:black'><span dir=RTL></span><span dir=RTL></span><span
    style='mso-spacerun:yes'> </span>رقم الاتصال الموحد : 19999 </span><span
    dir=LTR style='color:black'><o:p></o:p></span></p>
    <p dir=RTL style='margin:0in;margin-bottom:.0001pt;text-align:right;
    direction:rtl;unicode-bidi:embed'><span lang=AR-SA style='color:black'>البريد
    الإلكتروني</span><span dir=LTR></span><span dir=LTR></span><span dir=LTR
    style='color:black'><span dir=LTR></span><span dir=LTR></span><span
    style='mso-spacerun:yes'>  </span></span><span dir=LTR><a
    href="mailto:npc.drug@sfda.gov.sa">npc.drug@sfda.gov.sa</a><span
    style='color:black'>. :</span></span><span dir=RTL></span><span dir=RTL></span><span
    style='color:black'><span dir=RTL></span><span dir=RTL></span> </span><span
    dir=LTR style='color:black'><o:p></o:p></span></p>
    <p dir=RTL style='margin:0in;margin-bottom:.0001pt;text-align:right;
    direction:rtl;unicode-bidi:embed'><span lang=AR-SA style='color:black'>الموقع
    الإلكتروني</span><span dir=LTR></span><span dir=LTR></span><span dir=LTR
    style='color:black'><span dir=LTR></span><span dir=LTR></span><span
    style='mso-spacerun:yes'>  </span></span><span dir=LTR><span
    style='mso-field-code:" HYPERLINK "'><span class=MsoHyperlink>https://</span><span
    class=MsoHyperlink><span style='mso-bidi-language:AR-EG'>a</span>de.sfda.gov.sa</span><span
    class=MsoHyperlink><span style='font-size:13.5pt'> </span></span></span></span><span
    dir=LTR style='font-size:13.5pt;color:black'><span
    style='mso-spacerun:yes'> </span>:</span><span dir=RTL></span><span
    dir=RTL></span><span lang=AR-SA style='font-size:13.5pt;color:black'><span
    dir=RTL></span><span dir=RTL></span><span style='mso-spacerun:yes'> 
    </span></span><span lang=AR-SA style='color:black'><o:p></o:p></span></p>
    <p class=MsoNormal dir=RTL style='text-align:right;direction:rtl;
    unicode-bidi:embed'><span lang=AR-SA style='font-family:"Arial",sans-serif;
    mso-ascii-font-family:Calibri;mso-ascii-theme-font:minor-latin;mso-hansi-font-family:
    Calibri;mso-hansi-theme-font:minor-latin;mso-bidi-theme-font:minor-bidi;
    color:black'><o:p>&nbsp;</o:p></span></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
 <w:wrap type="square"/>
</v:shape><![endif]--><img width="522" height="93" alt="Text Box: - المركز الوطني للتيقظ الدوائي:
 رقم الاتصال الموحد : 19999 
البريد الإلكتروني  npc.drug@sfda.gov.sa. : 
الموقع الإلكتروني  https://ade.sfda.gov.sa  :  

" src="file:///C:/Users/M60F1~1.ALG/AppData/Local/Temp/msohtmlclip1/01/clip_image001.png" /></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>&nbsp;الإمارات العربية المتحدة</strong><strong>:</strong></p><p dir="RTL"><!--[if gte vml 1]><v:shape
 id="Text_x0020_Box_x0020_2" o:spid="_x0000_s1027" type="#_x0000_t202" style='position:absolute;
 left:0;text-align:left;margin-left:76.85pt;margin-top:3.75pt;width:396.6pt;
 height:94.1pt;z-index:251664384;visibility:visible;mso-wrap-style:square;
 mso-width-percent:0;mso-height-percent:0;mso-wrap-distance-left:9pt;
 mso-wrap-distance-top:0;mso-wrap-distance-right:9pt;
 mso-wrap-distance-bottom:0;mso-position-horizontal:absolute;
 mso-position-horizontal-relative:text;mso-position-vertical:absolute;
 mso-position-vertical-relative:text;mso-width-percent:0;mso-height-percent:0;
 mso-width-relative:page;mso-height-relative:page;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQC75UiUBQEAAB4CAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbKSRvU7DMBSF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"/><![endif]--></p><table cellpadding="0" cellspacing="0" align="left"><tbody><tr><td>&nbsp;</td></tr><tr><td>&nbsp;</td><td><table cellpadding="0" cellspacing="0" style="width:100%"><tbody><tr><td><p dir="RTL">قسم التيقظ الدوائي والأجهزة الطبية</p><p dir="RTL">صندوق بريد: 1853</p><p dir="RTL">هاتف: 80011111</p><p dir="RTL">بريد إلكتروني: pv@mohap.gov.ae</p><p dir="RTL">إدارة الدواء وزارة الصحة ووقاية المجتمع</p><p dir="RTL">دبي ، الإمارات العربية المتحدة</p><p dir="RTL">&nbsp;</p></td></tr></tbody></table></td></tr></tbody></table><p><strong>&nbsp;</strong></p><p>&nbsp;</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p>&nbsp;</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>دول الخليج العربي الأخرى:</strong></p><p dir="RTL"><!--[if gte vml 1]><v:shape id="Text_x0020_Box_x0020_1" o:spid="_x0000_s1026"
 type="#_x0000_t202" style='position:absolute;left:0;text-align:left;
 margin-left:76.85pt;margin-top:1.95pt;width:402.9pt;height:21.75pt;z-index:251665408;
 visibility:visible;mso-wrap-style:square;mso-width-percent:0;
 mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:text;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;
 mso-height-relative:margin;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQC75UiUBQEAAB4CAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbKSRvU7DMBSF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" fillcolor="window" strokeweight=".5pt">
 <v:path arrowok="t"/>
 <v:textbox>
  <![if !mso]>
  <table cellpadding=0 cellspacing=0 width="100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=MsoNormal dir=RTL style='text-align:right;direction:rtl;
    unicode-bidi:embed'><span lang=AR-SA style='font-size:12.0pt;mso-ansi-font-size:
    11.0pt;line-height:107%;font-family:"Arial",sans-serif;mso-ascii-font-family:
    Calibri;mso-ascii-theme-font:minor-latin;mso-hansi-font-family:Calibri;
    mso-hansi-theme-font:minor-latin;mso-bidi-theme-font:minor-bidi;color:black'>الرجاء
    الاتصال بالجهات الوطنية في كل دولة </span><span dir=LTR style='mso-bidi-font-size:
    12.0pt;line-height:107%;color:black'><o:p></o:p></span></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
</v:shape><![endif]--></p><table cellpadding="0" cellspacing="0" align="left"><tbody><tr><td>&nbsp;</td></tr><tr><td>&nbsp;</td><td><img width="544" height="35" alt="Text Box: الرجاء الاتصال بالجهات الوطنية في كل دولة " src="file:///C:/Users/M60F1~1.ALG/AppData/Local/Temp/msohtmlclip1/01/clip_image002.png" /></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><p dir="RTL">&nbsp;</p><p>&nbsp;</p><p dir="RTL"><strong>مجلس وزراء الصحة العرب</strong><strong>:</strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:546px"><tbody><tr><td style="vertical-align:top"><p><strong>إن هذا الدواء</strong></p><p dir="RTL"><strong>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>الدواء مستحضر يؤثر على صحتك واستهلاكه خلافا للتعليمات يعرضك للخطر.</strong></p><p dir="RTL"><strong>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>اتبع بدقة وصفة الطبيب وطريقة الاستعمال المنصوص عليها وتعليمات الصيدلي الذي صرفها لك.</strong></p><p dir="RTL"><strong>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>الطبيب والصيدلي هما الخبيران في الدواء، وفي نفعه وضرره.</strong></p><p dir="RTL"><strong>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>لا تقطع مدة العلاج المحددة لك من تلقاء نفسك.</strong></p><p dir="RTL"><strong>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>لا تكرر صرف الدواء بدون استشارة الطبيب</strong><strong> </strong><strong>المختص.</strong></p><p dir="RTL"><strong>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>لا تترك الأدوية في متناول الأطفال.</strong></p></td></tr></tbody></table><p><strong>مجلس وزراء الصحة العرب</strong></p><p><strong>واتحاد الصيادلة العرب&nbsp;&nbsp;&nbsp; </strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يحفظ&nbsp;بعيدًا&nbsp;عن رؤية ومتناول الأطفال.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تستعمل هذا الدواء بعد انتهاء مدّة الصلاحية المدوّنة على العلبة والأنبوب بعد كلمة (EXP).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يُحفظ في درجة حرارة لا تزيد عن ٣۰ درجة مئوية.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يُستخدم خلال 6 أشهر من فتح الأنبوب للمرة الأولي</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يجب عدم التخلّص من الأدوية عن طريق مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلي عن كيفية التخلّص من الأدوية التي لم تعد بحاجة إليها. فهذه التدابير تساعد في حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>ماهي محتويات كريم أزيبات</strong></p><p dir="RTL">كل جرام يحتوي على</p><p><strong>المواد الفعالة</strong>: حمض الأزيلايك. يحتوي كل جرام واحد من كريم أزيبات على 200 مجم (20٪) حمض الأزيلايك.</p><p>&nbsp;</p><p><strong>&nbsp;</strong></p><p><strong>المكونات الأخرى:</strong></p><p>جليسريل ستيرات / كحول سيتريل / سيتيل بالميتات / كوكوجليسريد (CUTINA CBS)، بولي إيثيلين جلايكول - 5 ستيرات الجليسريل (Arlacel 983)، الجلسرين، البروبيلين جليكول، سيتريل أوكتانوات (PCL Liquid 100)، حمض البنزويك، والماء النقي.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>كريم أزيبات هو كريم متجانس ناعم لونه أبيض إلى الأبيض المصفر</p><p>متوفر في أنبوب ألومنيوم سعة 30 جم داخل علبة كرتونية مع نشرة معلومات المريض.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مصنع البترجي للأدوية (بترجي فارما)</p><p dir="RTL">المملكة العربية السعودية، جدة، المنطقة الصناعية، المرحلة الرابعة، قطعة E2.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تمت مراجعة هذه النشرة في مارس 2023
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Azebat Cream
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                1 g of Azebat Cream contains 200 mg (20% w/w) azelaic acid.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Cream.
White to yellowish-white smooth homogeneous cream

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Topical treatment of acne vulgaris.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Method of administration</u></p><p>Cutaneous use</p><p><u>Dosage regimen</u></p><p>Azebat Cream should be applied to the affected areas of skin twice daily (mornings and evenings), and rubbed in gently. As a guide, 2.5 cm (approx. 0.5 g) of cream is sufficient for the entire facial area. If other areas of acne, in addition to the face, require treatment, for example, the chest and back, the amount of cream should be adjusted accordingly.</p><p>Patients with sensitive skin should be advised to use Azebat only once a day (in the evening) for the first week of treatment and then proceed to twice daily applications.</p><p>Before Azebat Cream is applied, the skin should be thoroughly cleaned with plain water and dried. A mild skin-cleansing agent may be used.</p><p>The duration of use of Azebat Cream can vary from patient to patient and also depends on the severity of the acne. In general, a distinct improvement becomes apparent after about 4 weeks. To obtain the best results, Azebat Cream should be used continuously over a period of several months (see Section 5.1 Pharmacodynamic properties).</p><p>It is important to continue to use Azebat Cream regularly over the entire period of treatment. However, in the event of intolerable skin irritation (see Section 4.8</p><p>Undesirable effects), the amount of cream per application should be reduced or the frequency of use of Azebat Cream should be reduced to once a day until the irritation ceases. If required, treatment might have to be temporarily interrupted for a few days.</p><p>&nbsp;</p><p><strong>&nbsp;</strong></p><p><strong>Additional information on special populations</strong></p><p><u>Paediatric population</u></p><p>Use in adolescents (12 - 18 years of age): dose adjustment is not required when</p><p>Azebat Cream is administered to adolescents aged 12 - 18 years.</p><p>The safety and efficacy of Azebat Cream in children below the age of 12 years have not been established.</p><p><u>Geriatric patients</u></p><p>No targeted studies have been performed in patients aged 65 and over.</p><p><u>Patients with hepatic impairment</u></p><p>No targeted studies have been performed in patients with hepatic impairment.</p><p><u>Patients with renal impairment</u></p><p>No targeted studies have been performed in patients with renal impairment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>For external use only.</p><p>Care should be taken when using Azebat Cream to avoid contact with the eyes, mouth and other mucous membranes, and patients should be instructed accordingly (see Section 5.3 Preclinical safety data). In the event of accidental contact, the eyes, mouth and/or affected mucous membranes should be washed with large amounts of water. If eye irritation persists, patients should consult a physician. The hands should be washed after each application of Azebat Cream.</p><p>Worsening of asthma in patients treated with azelaic acid has been reported rarely during post-marketing surveillance.</p><p>Azebat contains 2 mg of benzoic acid in each g. Benzoic acid may cause local irritation.</p><p>Azebat contains 125 mg propylene glycol in each g.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No interaction studies have been performed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Pregnancy</u></p><p>There are no adequate and well-controlled studies of topically administered azelaic acid in pregnant women.</p><p>Animal studies do indicate the potential for effects with respect to pregnancy, embryo-fetal development, parturition or postnatal development. However, the dose levels without observed adverse effects in animals ranged across studies from 3-32 times the maximum recommended human dose based on body surface area (see Section 5.3 Preclinical safety data).</p><p>Caution should be exercised when prescribing azelaic acid to pregnant women.</p><p>&nbsp;</p><p>&nbsp;</p><p><u>Lactation</u></p><p>Infants must not come into contact with treated skin/breast.</p><p>It is not known if azelaic acid is passed into breast milk in vivo. Due to low percutaneous absorption and since azelaic acid is not concentrated in milk, the amount of azelaic acid reaching the infant via mother&#39;s milk is approximately 0.01%.</p><p>This corresponds to less than 200 &mu;g per day following administration of the maximum recommended dose of 5 g Azebat 20% Cream twice daily. Caution should be exercised when Azebat Cream is administered to a nursing mother.</p><p><u>Fertility</u></p><p>There are no data on the effect of Azebat cream on human fertility. Results from animal studies showed no effect on fertility in male or female rats (see section 5.3 Preclinical safety data).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Azebat Cream has no influence on the ability to drive and use machines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>From clinical studies and post-marketing surveillance, the most frequently observed side-effects included application site burning, application site pruritus and application site erythema.</p><p>Frequencies of side-effects observed in clinical studies and post-marketing surveillance and given in the table below are defined according to the MedDRA frequency convention:</p><p>Very common (&ge;1/10), Common (&ge;1/100 to &lt;1/10), Uncommon (&ge;1/1,000 to &lt;1/100),</p><p>Rare (&ge;1/10,000 to &lt;1/1,000),Very rare (&lt;1/10,000),</p><p>Not known (cannot be estimated from the available data).</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" style="width:691px"><tbody><tr><td><p><strong>System Organ Class</strong></p></td><td><p><strong>Very Common</strong></p></td><td><p><strong>Common</strong></p></td><td><p><strong>Uncommon</strong></p></td><td><p><strong>Rare</strong></p></td><td><p><strong>Not known1</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Skin and subcutaneous tissue disorders</strong></p></td><td><p>&nbsp;</p></td><td><p>&nbsp;</p></td><td><p>seborrhoea, acne, skin depigmentation</p></td><td><p>cheilitis</p></td><td><p>Urticaria</p><p>&nbsp;</p><p>rash</p></td></tr><tr><td style="vertical-align:top"><p><strong>General disorders</strong></p><p><strong>and administration</strong></p><p><strong>site conditions</strong></p></td><td><p>application</p><p>site burning,</p><p>application</p><p>site pruritus,</p><p>application</p><p>site erythema</p></td><td><p>application site</p><p>exfoliation,</p><p>application site</p><p>pain, application</p><p>site dryness,</p><p>application site</p><p>discolouration,</p><p>application site irritation</p></td><td><p>application site</p><p>paraesthesia,</p><p>application site</p><p>dermatitis,</p><p>application site</p><p>discomfort,</p><p>application site</p><p>oedema</p></td><td><p>application site</p><p>vesicles, application</p><p>site eczema,</p><p>application site</p><p>warmth, application</p><p>site ulcer,</p></td><td><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p><strong>Immune system disorders</strong></p></td><td><p>&nbsp;</p></td><td><p>&nbsp;</p></td><td><p>&nbsp;</p></td><td><p>drug hypersensitivity, worsening of asthma (see section 4.4)</p></td><td><p>angioedema2, dermatitis contact2 , eye</p><p>swelling2,</p><p>swelling face2</p></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><p><sup>1</sup> <strong><em>These additional adverse reactions have been reported during post-approval use of Azebat cream(frequency unknown).</em></strong></p><p><sup>2</sup> <strong><em>may occur with hypersensitivity</em></strong></p><p>Generally, local skin irritation regresses in the course of treatment.</p><p>&nbsp;</p><p>To report any side effect(s):</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong><em>Saudi Arabia:</em></strong></p><p><!--[if gte vml 1]><v:shapetype
 id="_x0000_t202" coordsize="21600,21600" o:spt="202" path="m,l,21600r21600,l21600,xe">
 <v:stroke joinstyle="miter"/>
 <v:path gradientshapeok="t" o:connecttype="rect"/>
</v:shapetype><v:shape id="_x0000_s1026" type="#_x0000_t202" style='position:absolute;
 left:0;text-align:left;margin-left:18.05pt;margin-top:3.3pt;width:413.85pt;
 height:65.9pt;text-indent:0;z-index:251659776'>
 <v:textbox style='mso-next-textbox:#_x0000_s1026' inset="0,0,0,0"/>
</v:shape><![endif]--></p><table cellpadding="0" cellspacing="0" align="left"><tbody><tr><td>&nbsp;</td></tr><tr><td>&nbsp;</td><td><table cellpadding="0" cellspacing="0" style="width:100%"><tbody><tr><td><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The National Pharmacovigilance and Drug Safety Centre (NPC)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SFDA Call Center: 19999</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: https://ade.sfda.gov.sa/</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</p><p>&nbsp;</p></td></tr></tbody></table></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp; <em>United Arab Emirates</em></p><p><!--[if gte vml 1]><v:shape id="_x0000_s1028" type="#_x0000_t202"
 style='position:absolute;margin-left:18.05pt;margin-top:4.7pt;width:406.5pt;
 height:76.35pt;z-index:251661824'>
 <v:textbox style='mso-next-textbox:#_x0000_s1028' inset="0,0,0,0"/>
</v:shape><![endif]--></p><table cellpadding="0" cellspacing="0" align="left"><tbody><tr><td>&nbsp;</td></tr><tr><td>&nbsp;</td><td><table cellpadding="0" cellspacing="0" style="width:100%"><tbody><tr><td><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pharmacovigilance &amp; Medical Device section</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; P.O.Box: 1853</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tel: 80011111</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Email : pv@mohap.gov.ae</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Drug Department Ministry of Health &amp; Prevention Dubai, UAE</p></td></tr></tbody></table></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p>&nbsp;</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp; <em>Other GCC states</em></p><p><!--[if gte vml 1]><v:shape id="_x0000_s1027" type="#_x0000_t202"
 style='position:absolute;margin-left:18.05pt;margin-top:4.7pt;width:406.5pt;
 height:19.05pt;z-index:251660800'>
 <v:textbox style='mso-next-textbox:#_x0000_s1027' inset="0,0,0,0"/>
</v:shape><![endif]--></p><table cellpadding="0" cellspacing="0" align="left"><tbody><tr><td>&nbsp;</td></tr><tr><td>&nbsp;</td><td><table cellpadding="0" cellspacing="0" style="width:100%"><tbody><tr><td><p><em>&nbsp;</em><em>Please contact the relevant competent authority</em></p></td></tr></tbody></table></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No known cases of azelaic acid overdosage resulting from topical administration of Azebat Cream have been reported. Results from acute toxicity studies do not indicate that any risk of acute intoxication is to be expected following a single dermal application of an overdose (application over a large area under conditions favourable to absorption) or inadvertent oral ingestion. Due to the very low local and systemic toxicity of azelaic acid intoxication is unlikely.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: other anti-acne preparations for topical use.</p><p>ATC Code: D10AX03</p><p>The antimicrobial action and a direct influence on follicular hyperkeratosis are assumed to be the basis for the therapeutic efficacy of Azebat in acne.</p><p>Clinically, a significant reduction of the colonization density of Propionibacterium acnes and a significant reduction of the fraction of free fatty acids in the skin surface lipids is observed.</p><p>In vitro and in vivo, azelaic acid inhibits the proliferation of keratinocytes and normalizes the disturbed terminal epidermal differentiation processes in acne. In the rabbit ear model, azelaic acid accelerates the comedolysis of tetradecane-induced comedones.</p><p>There is a clinical experience for a continuous application time period of up to one year.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>After dermal administration of the cream, azelaic acid penetrates all layers of human skin. The penetration is more rapid into damaged skin than into intact skin. A total of 3.6% of the administered dose was absorbed percutaneously after a single topical administration of 1 g azelaic acid (5 g cream).</p><p>A portion of the azelaic acid which is absorbed through the skin is eliminated unchanged with the urine. The remaining portion is metabolized through beta-oxidation into short-chained dicarboxylic acids (C7, C5 carboxylic acids) which have likewise been found in the urine.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Non-clinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, contact hypersensitivity, genotoxicity and toxicity to reproduction and development.</p><p>Embryofetal developmental studies with oral administration of azelaic acid to rats, rabbits, and cynomolgus monkeys during the period of organogenesis revealed embryotoxicity at doses where some maternal toxicity was noted. No teratogenic effects were observed. The embryofetal NOAEL was 32 times the MRHD based on BSA in rats, 6.5 times the MRHD based on BSA in rabbits and 19 times the MRHD based on BSA in monkeys (see section 4.6 Fertility, pregnancy and lactation).</p><p>In a peri- and post-natal developmental study in rats where azelaic acid was administered orally from gestational day 15 to through day 21 postpartum slight disturbances in the post-natal development of fetuses were noted at oral doses that generated some maternal toxicity. The NOAEL was 3 times the MRHD based on BSA. No effects on the sexual maturation of the fetuses were noted in this study.</p><p>Studies on impairment of fertility in animals have not produced any evidence for such a risk during therapeutic use ofAzebat.</p><p>If azelaic acid came into contact with the eyes of monkeys and rabbits, signs of moderate to severe irritation became evident. Therefore, contact with the eyes should be avoided.</p><p>Azelaic acid administered once intravenously had no effects on the nervous system (Irwin test), cardiovascular function, intermediary metabolism, smooth muscles and liver and kidney function</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Glyceryl Stearate/ Cetearyl Alcohol /Cetyl Palmitate /Cocoglycerides (CUTINA CBS),</p><p>PEG &ndash; 5 Glyceryl stearate (Arlacel 983)</p><p>Glycerine</p><p>Propylene Glycol</p><p>Cetearyl Octanoate (PCL Liquid 100)</p><p>Benzoic acid</p><p>purified water</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None stated.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2 years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not Store above 30&deg;C.</p><p>To be used within 6 months from the first opening of the tube</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Azebat</strong> cream is available in an aluminium tube of&nbsp; 30 g inside a carton box along with a patient information leaflet.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Batterjee pharmaceutical Factory (BATTERJEE PHARMA)
Plot E2, Phase 4, Industrial City, Jeddah, Saudi Arabia.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                March 2023
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>